France· FR:60116714
NILOTINIB ACCORD 200 mg, gélule
A medicinal product containing nilotinib, registered in France by ACCORD HEALTHCARE (ESPAGNE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- NILOTINIB
- Manufacturer
- ACCORD HEALTHCARE (ESPAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip133400930303658plaquettes PVC PVDC aluminium de 28 gélulesEUR 304.12
- cip133400930303696plaquettes PVC PVDC aluminium de 112 (4 x 28) gélules (conditionnement multiple)EUR 1.17
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nilotinib in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaNILOTINIB ACCORDAccord Healthcare S.L.U., Barcelona
- United StatesnilotinibTorrent Pharmaceuticals Limited
- SwitzerlandNilotinib Accord 200 mg, HartkapselnAccord Healthcare AG
- BelgiumNilotinib Accord 200 mgAccord Healthcare
- SpainNILOTINIB ACCORD 200 MG CAPSULAS DURAS EFGAccord Healthcare S.L.U.
- NetherlandsNilotinib Accord 200 mg, harde capsulesAccord Healthcare S.L.U.
- SwedenNilotinib Accord 200 mg Kapsel, hårdAccord Healthcare S.L.U.
- PolandNilotinib AccordAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Nilotinib Stada, Nilotinib Teva
- Belgium · Nilotinb Eg, Nilotinib
- Bulgaria · Нилотиниб Зентива, Нилотиниб Стада
- Cyprus · Nilotinib Bioars, Nilotinib Olpha
- Czechia · Nilotinib, Nilotinib Stada
- Germany · Nilotinib Al, Nilotinib Al 150 Mg Hartkapseln Al
- Denmark · Nilotinib "olpha", Nilotinib Stada
- Estonia · Nilotinib Olpha, Nilotinib Stada
- Spain · Nilotinib Cipla, Nilotinib Eugia
- Finland · Nilotinib Stada, Nilotinib Zentiva
- United Kingdom (Northern Ireland) · Nilotinib Amarox, Nilotinib Teva Uk
- Greece · Lobynia, Nilotinib Anabiosis
- Croatia · Nilmat, Nilotinib Devatis
- Hungary · Krufton, Nilotinib
- Ireland · Nilotinib Clonmel
- Iceland · Nilotinib, Nilotinib Accord
- Italy · Nilotinib Cipla, Nilotinib Eg
- Liechtenstein · Nilotinib Accord, Tasigna
- Lithuania · Krufton, Nilotinib Olpha
- Luxembourg · Nilotinib Eg, Nilotinib Eugia
- Latvia · Krufton, Nilotinib Olpha
- Malta · Nilotinib Hydrochloride Dihydrate Clonmel, Nilotinib Olpha
- Netherlands · Nilotinib Cf, Nilotinib Cipla
- Norway · Nilotinib Accord, Nilotinib Cipla
- Poland · Nilotinib Stada, Nilotinib Viatris
- Portugal · Nilotinib Eugia, Nilotinib Generis
- Romania · Krufton, Nilotinib Cipla
- Sweden · Nilotinib Cipla, Nilotinib Devatis
- Slovenia · Nilmat, Nilotinib Stada
- Slovakia · Krufton, Nilotinib
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dff71018-818e-48b1-9320-048494e03403 GET /v1/drugs/dff71018-818e-48b1-9320-048494e03403?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "60116714",
"date_amm": "2024-08-22",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/24/1845",
"substance": "NILOTINIB",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about nilotinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.